Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Other Liabilities

Rigel Pharmaceuticals Other Liabilities Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Other Liabilities from 2010 to 2020.
  • Rigel Pharmaceuticals Other Liabilities for the quarter ending June 06, 2020 was $5m a -403.52% decrease of -20m year over year
  • Rigel Pharmaceuticals Other Liabilities for the last 12 months ending June 06, 2020 was $5m a -403.52% decrease of -20m year over year
  • Rigel Pharmaceuticals Annual Other Liabilities for 2019 was $7m a 76.96% increase of 5m from 2018
  • Rigel Pharmaceuticals Annual Other Liabilities for 2018 was $1m a 91.46% increase of 1m from 2017
  • Rigel Pharmaceuticals Annual Other Liabilities for 2017 was $0m a -305.47% decrease of 0m from 2016
Other Balance Sheet Metrics:
  • Rigel Pharmaceuticals Total Assets for the quarter ending September 09, 2018 was $123m a 3.29% increase of 4m year over year
  • Rigel Pharmaceuticals Total Equity for the quarter ending September 09, 2018 was $103m a 2.73% increase of 3m year over year
View Chart On Koyfin

Quarterly RIGL Other Liabilities Data

06/2020$5m
03/2020$7m
12/2019$7m
09/2019$25m
06/2019$26m
03/2019$26m
12/2018$1m
06/2018$0m
03/2018$0m
12/2017$0m

Annual RIGL Other Liabilities Data

2019$7m
2018$1m
2017$0m
2016$1m
2015$7m
2014$12m
2013$8m
2012$9m
2011$9m
2010$9m